comparemela.com

Latest Breaking News On - Tiziana foralumab - Page 1 : comparemela.com

Tiziana Advances Phase 2 Site Selection For Its Lead Clinical Program In Non-Active Secondary Progressive Multiple Sclerosis (SPMS) And The Company Prepares For Six-Month Clinical Data Update - Roche Holding (OTC:RHHBY), Sanofi (NASDAQ:SNY)

Tiziana Life Sciences Ltd announces positive clinical data from a person with secondary progressive multiple sclerosis

Tiziana Life Sciences Ltd shares rose by 22% after it announced positive clinical data from a person with secondary progressive multiple sclerosis receiving.

Tiziana Life Sciences Ltd announces positive clinical data from a person with secondary progressive multiple sclerosis

Tiziana Life Sciences Ltd shares rose by 22% after it announced positive clinical data from a person with secondary progressive multiple sclerosis receiving.

SMALL-CAP WINNERS & LOSERS: EnQuest falls on production output warning

SMALL-CAP WINNERS & LOSERS: EnQuest falls on production output warning
lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.

Tiziana Life Sciences PLC to present at BIO CEO & Investor online conference

Tiziana Life Sciences PLC to present at BIO CEO & Investor online conference
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.